SPRAVATO® (esketamine)

SPRAVATO® (esketamine) is the first FDA-approved nasal spray for adults with treatment-resistant depression. Used in combination with an oral antidepressant, Spravato has been shown to quickly and effectively treat depression. FDA-approved in 2019, Spravato is covered by many insurance companies and administered right in our office. Spravato a self-administered nasal spray that is handed to you to administer. You then relax in our office while we supervise your treatment. Relief is often immediate.

and we’re here to help.